Boehringer Ingelheim discovers a remedy for print pain
Company: Boehringer Ingelheim
Location: Sydney, NSW
The Boehringer Ingelheim group is one of the world’s leading 20 pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 42,000 employees.
Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
In Australia and New Zealand, Boehringer Ingelheim employs around 400 staff and is active in the areas of Prescription Medicine, Consumer Health Care and Animal Health.
The company’s office in Sydney is focused primarily on market development, says Joe Helo, IS manager for Australia and New Zealand. “The majority of our staff are in sales and marketing. We do some research here, but not in laboratories we do mainly stage four clinical trials.”
Boehringer Ingelheim faced the following challenges:
- The company’s unstructured and ad hoc print capabilities were wasting money and resources and causing performance issues such as paper jams and poor print quality.
- A lack of security for employees who handled confidential documents.